Artigo Acesso aberto Revisado por pares

The economic burden of pulmonary arterial hypertension (PAH) in the US on payers and patients

2014; BioMed Central; Volume: 14; Issue: 1 Linguagem: Inglês

10.1186/s12913-014-0676-0

ISSN

1472-6963

Autores

Mirko Sikirica, Şerban R. Iorga, Tim Bancroft, Jesse Potash,

Tópico(s)

Cardiovascular Issues in Pregnancy

Resumo

Pulmonary arterial hypertension (PAH) is a rare condition that can ultimately lead to right heart failure and death. In this study we estimated the health care costs and resource utilization associated with PAH in a large US managed care health plan.

Referência(s)